What is the management of marasmus in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Marasmus in Children

The management of marasmus in children requires a comprehensive therapeutic approach with immediate nutritional rehabilitation using ready-to-use therapeutic food (RUTF) under community-based management of acute malnutrition (CMAM) protocols, with recovery rates approaching 90% under optimal conditions. 1

Assessment and Diagnosis

  • Marasmus is characterized by severe wasting without edema, representing one form of severe acute malnutrition (SAM)

  • Key anthropometric criteria for diagnosis:

    • Weight-for-height Z-score < -3 SD
    • Mid-upper arm circumference (MUAC) < 11.5 cm in children 6-59 months
    • Visible severe wasting
  • Clinical features to assess:

    • Severe muscle wasting with "old man" appearance
    • Absence of edema (distinguishes from kwashiorkor)
    • Skin appears loose and wrinkled ("baggy pants")
    • Irritability and apathy
    • Assess for comorbidities, especially infections

Treatment Protocol

Step 1: Triage and Emergency Management

  • Perform rapid triage assessment for life-threatening complications 2:

    • Respiratory distress or irregular breathing
    • Signs of shock (tachycardia, cold extremities, capillary refill >2 seconds)
    • Depressed consciousness
    • Severe dehydration
    • Hypoglycemia
  • For emergency cases with complications:

    • Secure airway and provide oxygen if needed
    • Treat hypoglycemia with 10% glucose (5 ml/kg)
    • Manage shock with careful fluid resuscitation (20 ml/kg of colloid or 0.9% saline) 2
    • Monitor for respiratory deterioration during fluid resuscitation

Step 2: Nutritional Rehabilitation

For Uncomplicated Marasmus:

  • Implement community-based management using RUTF at 175-200 kcal/kg/day 1
  • RUTF should provide:
    • Energy: 520-550 kcal/100g
    • Protein: 10-12% of total energy
    • Lipids: 45-60% of total energy
    • Essential micronutrients

For Complicated Marasmus (with medical complications):

  • Initial stabilization phase (1-7 days):

    • Start F-75 formula (75 kcal/100ml, 0.9g protein/100ml)
    • Provide in small, frequent feeds (8-12 feeds/24 hours)
    • Target 100-130 kcal/kg/day initially
    • Monitor for refeeding syndrome
  • Rehabilitation phase:

    • Transition to F-100 formula (100 kcal/100ml, 2.9g protein/100ml)
    • Gradually increase to 150-220 kcal/kg/day
    • Continue until reaching target weight (usually -1 SD weight-for-height)

Step 3: Antibiotic Therapy

  • Provide empiric antibiotics even in uncomplicated cases 2

  • First-line options:

    • Amoxicillin (RR 1.05; 95% CI 1.00-1.11 for nutritional recovery) 2
    • Alternative: Cefdinir (shown to reduce mortality compared to placebo) 2
  • For complicated cases with suspected sepsis:

    • Ampicillin + gentamicin (first choice) 2
    • Alternative: Amikacin + cloxacillin or cefotaxime/ceftriaxone 2

Step 4: Management of Complications

  • Diarrhea:

    • Provide ORS after each loose stool (100-200 ml for a 3-year-old) 3
    • Continue feeding during diarrheal episodes
    • Avoid antimotility agents in children 3
  • Malabsorption:

    • Address underlying bile acid deficiency that contributes to fat malabsorption 4
    • Consider lactose-free formulas initially as lactase deficiency is common 2
  • Infections:

    • Screen for HIV and tuberculosis as these significantly increase mortality risk (HR=1.8 for HIV) 5
    • Treat specific infections according to identified pathogens

Monitoring and Follow-up

  • Daily monitoring during initial phase:

    • Weight gain (target: 5-10g/kg/day during rehabilitation)
    • Vital signs, especially respiratory rate
    • Edema development (may indicate refeeding syndrome)
    • Appetite and feed tolerance
  • Laboratory monitoring:

    • Electrolytes (especially potassium, sodium)
    • Blood glucose
    • Hemoglobin (anemia is common, present in 80% of cases) 6
    • Serum albumin (typically low in marasmus) 6

Discharge Criteria and Follow-up

  • Discharge when:

    • Weight-for-height reaches ≥ -2 SD or
    • MUAC ≥ 12.5 cm with no edema for 2 consecutive weeks
    • Child is clinically well with good appetite
  • Post-discharge follow-up:

    • Weekly visits for first month
    • Biweekly for second month
    • Monthly thereafter until fully recovered

Common Pitfalls to Avoid

  • Avoid rapid refeeding which can cause refeeding syndrome with potentially fatal electrolyte imbalances
  • Don't withhold food during diarrhea - continued feeding is essential for intestinal mucosal recovery 2
  • Don't use standard fluid resuscitation protocols in severely malnourished children with shock - use more cautious fluid administration
  • Avoid oral quinine for malaria treatment in young children as it is unpalatable 2
  • Don't neglect screening for comorbidities like HIV and TB which significantly increase mortality risk

Long-term Considerations

  • Address underlying causes of malnutrition:

    • Food insecurity
    • Chronic infections
    • Poor complementary feeding practices
    • Environmental enteropathy
  • Monitor for cognitive and developmental delays

  • Implement growth monitoring to prevent relapse

  • Provide caregiver education on optimal feeding practices

Implementation of standardized WHO protocols for marasmus management has been shown to significantly improve outcomes and reduce mortality rates 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.